1	Transactivation	Transactivation	_	_	_	_	_	_	_
2	by	by	_	_	_	_	_	_	_
3	CIITA	CIITA	_	_	_	_	_	_	_
4	,	,	_	_	_	_	_	_	_
5	the	the	_	_	_	_	_	_	_
6	type	type	_	_	_	_	_	_	_
7	II	ii	_	_	_	_	_	_	_
8	bare	bare	_	_	_	_	_	_	_
9	lymphocyte	lymphocyte	_	_	_	_	_	_	_
10	syndrome-associated	syndrome-associated	_	_	_	_	_	_	_
11	factor	factor	_	_	_	_	_	_	_
12	,	,	_	_	_	_	_	_	_
13	requires	require	_	_	_	_	_	_	_
14	participation	participation	_	_	_	_	_	_	_
15	of	of	_	_	_	_	_	_	_
16	multiple	multiple	_	_	_	_	_	_	_
17	regions	region	_	_	_	_	_	_	_
18	of	of	_	_	_	_	_	_	_
19	the	the	_	_	_	_	_	_	_
20	TATA	TATA	_	_	_	_	_	_	_
21	box	box	_	_	_	_	_	_	_
22	binding	binding	_	_	_	_	_	_	_
23	protein	protein	_	_	_	_	_	_	_
24	.	.	_	_	_	_	_	_	_

1	CIITA	CIITA	_	_	_	_	_	_	_
2	is	be	_	_	_	_	_	_	_
3	a	a	_	_	_	_	_	_	_
4	positive	positive	_	_	_	_	_	_	_
5	regulator	regulator	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	class	class	_	_	_	_	_	_	_
8	II	ii	_	_	_	_	_	_	_
9	major	major	_	_	_	_	_	_	_
10	histocompatibility	histocompatibility	_	_	_	_	_	_	_
11	complex	complex	_	_	_	_	_	_	_
12	gene	gene	_	_	_	_	_	_	_
13	transcription	transcription	_	_	_	_	_	_	_
14	that	that	_	_	_	_	_	_	_
15	has	have	_	_	_	_	_	_	_
16	been	be	_	_	_	_	_	_	_
17	found	find	_	_	_	_	_	_	_
18	to	to	_	_	_	_	_	_	_
19	be	be	_	_	_	_	_	_	_
20	defective	defective	_	_	_	_	_	_	_
21	in	in	_	_	_	_	_	_	_
22	one	one	_	_	_	_	_	_	_
23	of	of	_	_	_	_	_	_	_
24	the	the	_	_	_	_	_	_	_
25	five	five	_	_	_	_	_	_	_
26	complementation	complementation	_	_	_	_	_	_	_
27	groups	group	_	_	_	_	_	_	_
28	of	of	_	_	_	_	_	_	_
29	class	class	_	_	_	_	_	_	_
30	II	ii	_	_	_	_	_	_	_
31	major	major	_	_	_	_	_	_	_
32	histocompatibility	histocompatibility	_	_	_	_	_	_	_
33	complex-negative	complex-negative	_	_	_	_	_	_	_
34	cell	cell	_	_	_	_	_	_	_
35	lines	line	_	_	_	_	_	_	_
36	.	.	_	_	_	_	_	_	_

1	Its	its	_	_	_	_	_	_	_
2	N-terminal	n-terminal	_	_	_	_	_	_	_
3	region	region	_	_	_	_	_	_	_
4	is	be	_	_	_	_	_	_	_
5	capable	capable	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	activating	activate	_	_	_	_	_	_	_
8	transcription	transcription	_	_	_	_	_	_	_
9	from	from	_	_	_	_	_	_	_
10	a	a	_	_	_	_	_	_	_
11	reporter	reporter	_	_	_	_	_	_	_
12	gene	gene	_	_	_	_	_	_	_
13	when	when	_	_	_	_	_	_	_
14	fused	fuse	_	_	_	_	_	_	_
15	to	to	_	_	_	_	_	_	_
16	a	a	_	_	_	_	_	_	_
17	DNA	dna	_	_	_	_	_	_	_
18	binding	binding	_	_	_	_	_	_	_
19	domain	domain	_	_	_	_	_	_	_
20	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	have	have	_	_	_	_	_	_	_
3	investigated	investigate	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	mechanism	mechanism	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	transactivation	transactivation	_	_	_	_	_	_	_
8	mediated	mediate	_	_	_	_	_	_	_
9	by	by	_	_	_	_	_	_	_
10	the	the	_	_	_	_	_	_	_
11	CIITA	CIITA	_	_	_	_	_	_	_
12	activation	activation	_	_	_	_	_	_	_
13	domain	domain	_	_	_	_	_	_	_
14	by	by	_	_	_	_	_	_	_
15	studying	study	_	_	_	_	_	_	_
16	its	its	_	_	_	_	_	_	_
17	role	role	_	_	_	_	_	_	_
18	in	in	_	_	_	_	_	_	_
19	the	the	_	_	_	_	_	_	_
20	process	process	_	_	_	_	_	_	_
21	of	of	_	_	_	_	_	_	_
22	transcription	transcription	_	_	_	_	_	_	_
23	initiation	initiation	_	_	_	_	_	_	_
24	and	and	_	_	_	_	_	_	_
25	elongation	elongation	_	_	_	_	_	_	_
26	.	.	_	_	_	_	_	_	_

1	Specifically	specifically	_	_	_	_	_	_	_
2	the	the	_	_	_	_	_	_	_
3	altered	altered	_	_	_	_	_	_	_
4	specificity	specificity	_	_	_	_	_	_	_
5	TBP	TBP	_	_	_	_	_	_	_
6	(	(	_	_	_	_	_	_	_
7	TATA	TATA	_	_	_	_	_	_	_
8	box	box	_	_	_	_	_	_	_
9	binding	binding	_	_	_	_	_	_	_
10	protein	protein	_	_	_	_	_	_	_
11	)	)	_	_	_	_	_	_	_
12	assay	assay	_	_	_	_	_	_	_
13	has	have	_	_	_	_	_	_	_
14	been	be	_	_	_	_	_	_	_
15	used	use	_	_	_	_	_	_	_
16	to	to	_	_	_	_	_	_	_
17	analyze	analyze	_	_	_	_	_	_	_
18	the	the	_	_	_	_	_	_	_
19	response	response	_	_	_	_	_	_	_
20	of	of	_	_	_	_	_	_	_
21	the	the	_	_	_	_	_	_	_
22	CIITA	CIITA	_	_	_	_	_	_	_
23	activation	activation	_	_	_	_	_	_	_
24	domain	domain	_	_	_	_	_	_	_
25	to	to	_	_	_	_	_	_	_
26	mutations	mutation	_	_	_	_	_	_	_
27	in	in	_	_	_	_	_	_	_
28	TBP	TBP	_	_	_	_	_	_	_
29	known	know	_	_	_	_	_	_	_
30	to	to	_	_	_	_	_	_	_
31	disrupt	disrupt	_	_	_	_	_	_	_
32	its	its	_	_	_	_	_	_	_
33	interaction	interaction	_	_	_	_	_	_	_
34	with	with	_	_	_	_	_	_	_
35	its	its	_	_	_	_	_	_	_
36	associated	associate	_	_	_	_	_	_	_
37	general	general	_	_	_	_	_	_	_
38	factors	factor	_	_	_	_	_	_	_
39	.	.	_	_	_	_	_	_	_

1	Transactivation	Transactivation	_	_	_	_	_	_	_
2	by	by	_	_	_	_	_	_	_
3	CIITA	CIITA	_	_	_	_	_	_	_
4	was	be	_	_	_	_	_	_	_
5	extremely	extremely	_	_	_	_	_	_	_
6	sensitive	sensitive	_	_	_	_	_	_	_
7	to	to	_	_	_	_	_	_	_
8	a	a	_	_	_	_	_	_	_
9	mutation	mutation	_	_	_	_	_	_	_
10	in	in	_	_	_	_	_	_	_
11	TBP	TBP	_	_	_	_	_	_	_
12	that	that	_	_	_	_	_	_	_
13	in	in	_	_	_	_	_	_	_
14	yeast	yeast	_	_	_	_	_	_	_
15	is	be	_	_	_	_	_	_	_
16	known	know	_	_	_	_	_	_	_
17	to	to	_	_	_	_	_	_	_
18	abolish	abolish	_	_	_	_	_	_	_
19	VP16-mediated	vp16-mediated	_	_	_	_	_	_	_
20	transcription	transcription	_	_	_	_	_	_	_
21	but	but	_	_	_	_	_	_	_
22	leaves	leave	_	_	_	_	_	_	_
23	basal	basal	_	_	_	_	_	_	_
24	transcription	transcription	_	_	_	_	_	_	_
25	unaffected	unaffected	_	_	_	_	_	_	_
26	.	.	_	_	_	_	_	_	_

1	A	a	_	_	_	_	_	_	_
2	TBP	TBP	_	_	_	_	_	_	_
3	mutant	mutant	_	_	_	_	_	_	_
4	defective	defective	_	_	_	_	_	_	_
5	in	in	_	_	_	_	_	_	_
6	interaction	interaction	_	_	_	_	_	_	_
7	with	with	_	_	_	_	_	_	_
8	TBP-associated	tbp-associated	_	_	_	_	_	_	_
9	factor	factor	_	_	_	_	_	_	_
10	TAFII250	tafii250	_	_	_	_	_	_	_
11	also	also	_	_	_	_	_	_	_
12	failed	fail	_	_	_	_	_	_	_
13	to	to	_	_	_	_	_	_	_
14	mediate	mediate	_	_	_	_	_	_	_
15	transactivation	transactivation	_	_	_	_	_	_	_
16	through	through	_	_	_	_	_	_	_
17	the	the	_	_	_	_	_	_	_
18	CIITA	CIITA	_	_	_	_	_	_	_
19	activation	activation	_	_	_	_	_	_	_
20	domain	domain	_	_	_	_	_	_	_
21	.	.	_	_	_	_	_	_	_

1	Certain	certain	_	_	_	_	_	_	_
2	interactions	interaction	_	_	_	_	_	_	_
3	between	between	_	_	_	_	_	_	_
4	TBP	TBP	_	_	_	_	_	_	_
5	and	and	_	_	_	_	_	_	_
6	general	general	_	_	_	_	_	_	_
7	factors	factor	_	_	_	_	_	_	_
8	that	that	_	_	_	_	_	_	_
9	are	be	_	_	_	_	_	_	_
10	specifically	specifically	_	_	_	_	_	_	_
11	required	require	_	_	_	_	_	_	_
12	for	for	_	_	_	_	_	_	_
13	acidic	acidic	_	_	_	_	_	_	_
14	activation	activation	_	_	_	_	_	_	_
15	domains	domain	_	_	_	_	_	_	_
16	were	be	_	_	_	_	_	_	_
17	also	also	_	_	_	_	_	_	_
18	required	require	_	_	_	_	_	_	_
19	for	for	_	_	_	_	_	_	_
20	CIITA-mediated	ciita-mediated	_	_	_	_	_	_	_
21	transactivation	transactivation	_	_	_	_	_	_	_
22	to	to	_	_	_	_	_	_	_
23	reach	reach	_	_	_	_	_	_	_
24	its	its	_	_	_	_	_	_	_
25	full	full	_	_	_	_	_	_	_
26	potential	potential	_	_	_	_	_	_	_
27	.	.	_	_	_	_	_	_	_

1	Finally	finally	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	like	like	_	_	_	_	_	_	_
4	VP16	VP16	_	_	_	_	_	_	_
5	,	,	_	_	_	_	_	_	_
6	CIITA	CIITA	_	_	_	_	_	_	_
7	was	be	_	_	_	_	_	_	_
8	able	able	_	_	_	_	_	_	_
9	to	to	_	_	_	_	_	_	_
10	stimulate	stimulate	_	_	_	_	_	_	_
11	elongation	elongation	_	_	_	_	_	_	_
12	of	of	_	_	_	_	_	_	_
13	transcription	transcription	_	_	_	_	_	_	_
14	.	.	_	_	_	_	_	_	_

1	Overall	overall	_	_	_	_	_	_	_
2	the	the	_	_	_	_	_	_	_
3	mechanism	mechanism	_	_	_	_	_	_	_
4	of	of	_	_	_	_	_	_	_
5	transactivation	transactivation	_	_	_	_	_	_	_
6	by	by	_	_	_	_	_	_	_
7	the	the	_	_	_	_	_	_	_
8	human	human	_	_	_	_	_	_	_
9	B-cell-specific	b-cell-specific	_	_	_	_	_	_	_
10	CIITA	CIITA	_	_	_	_	_	_	_
11	is	be	_	_	_	_	_	_	_
12	very	very	_	_	_	_	_	_	_
13	similar	similar	_	_	_	_	_	_	_
14	to	to	_	_	_	_	_	_	_
15	that	that	_	_	_	_	_	_	_
16	mediated	mediate	_	_	_	_	_	_	_
17	by	by	_	_	_	_	_	_	_
18	the	the	_	_	_	_	_	_	_
19	herpes	herpes	_	_	_	_	_	_	_
20	virus	virus	_	_	_	_	_	_	_
21	transactivator	transactivator	_	_	_	_	_	_	_
22	VP16	vp16	_	_	_	_	_	_	_
23	in	in	_	_	_	_	_	_	_
24	the	the	_	_	_	_	_	_	_
25	ways	way	_	_	_	_	_	_	_
26	that	that	_	_	_	_	_	_	_
27	have	have	_	_	_	_	_	_	_
28	been	be	_	_	_	_	_	_	_
29	tested	test	_	_	_	_	_	_	_
30	.	.	_	_	_	_	_	_	_

